Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult
Ischemic heart disease is the main cause of death globally. Cardioprotection is the process whereby mechanisms that reduce myocardial damage, and activate protective factors, contribute to the preservation of the heart. Targeting these processes could be a new strategy in the treatment of post-ische...
Main Authors: | Ozlem Ozen Karakus, Noureldien H. E. Darwish, Thangirala Sudha, Taher A. Salaheldin, Kazutoshi Fujioka, Peter C. Taylor Dickinson, Brian Weil, Shaker A. Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/11/1713 |
Similar Items
-
Correction: Karakus et al. Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. <em>Biomedicines</em> 2021, <em>9</em>, 1713
by: Ozlem Ozen Karakus, et al.
Published: (2022-06-01) -
Triiodothyronine levels and mortality in children with sepsis and septic shock
by: Cynthea Prima Destariani, et al.
Published: (2018-03-01) -
Free triiodothyronine predicts the risk of developing diabetic kidney disease
by: Weihong Li, et al.
Published: (2023-10-01) -
The role of triiodothyronine (T3) and T3/free thyroxine (fT4) in glucose metabolism during pregnancy: the Ma’anshan birth cohort study
by: Beibei Zhu, et al.
Published: (2021-06-01) -
Triiodothyronine Acts as a Smart Influencer on Hsp90 via a Triiodothyronine Binding Site
by: Lu Fan, et al.
Published: (2022-06-01)